SCHEMBL4740418

SCHEMBL4740418

S=c1n(-c2ccccc2)ccn1-c1ccc2cccc-2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
PDE4B Q07343 1/20 0.31
NPC1 O15118 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NQO2 P16083 1/20 0.31
PRKDC P78527 1/20 0.31
CYP2E1 P05181 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2A6 P11509 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2B6 P20813 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089567 0.69 BIRC5 (0.40) RAB9AALDH1A1NPC1MAPT
SCHEMBL4357698 0.61 PRKDC (0.36) RAB9AALDH1A1NPC1POLBMAPT
SCHEMBL721718 0.60 SMN1; SMN2 (0.44) KDM4ELMNAPKMRAB9AALDH1A1
Hydrochloric Acid SCHEMBL9937226 0.59 SMN1; SMN2 (0.43) KDM4ELMNAPKMRAB9AALDH1A1
SCHEMBL4340657 0.59 ALDH1A1 (0.61) PKMALDH1A1HPGDPOLBMAPT
SCHEMBL4344550 0.59 ALDH1A1 (0.61) PKMALDH1A1HPGDPOLBMAPT
SCHEMBL76097 0.58 CYP2E1 (0.58) LMNAPKMRAB9AALDH1A1HPGD
SCHEMBL27736349 0.58 ALDH1A1 (0.42) ALDH1A1HPGDNQO2CYP2E1CYP3A4
SCHEMBL11668799 0.58 ASAH1 (0.42) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL3415966 0.57 ALDH1A1 (0.67) KDM4ELMNAPKMRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO disclosed